September 5-7, 2024
Essen / Germany + ONLINE
PROGRAM ▪ PROGRAMM
PROGRAMM - der Infoflyer für Sie: Download PDF
THURSDAY, SEPTEMBER 5, 2024
PRE-PROGRAM: BREAST CANCER
ANZEICHNUNGSKURS BRUSTCHIRURGIE „MALEN NACH ZAHLEN“
09.00 - 09.15 am
Welche Implantatloge wann?
Implantatwechsel – Tipps und Tricks
V. Bjelic-Radisic, S. Kümmel
09.15 - 09.45 am
Aesthetic Fat Closure nach Mastektomie – Was ist das und wie mache ich das am besten?
H. Rotthaus, O. Chiari
09.45 - 10.05 am
Welche Implantatform, wann?
M. Warm
10.10 - 10.25 am
23–30 Punkte Programm der KEM zur Vermeidung von Infektionen bei der Implantatchirurgie – eine erste Auswertung
O. Chiari
10.25 - 10.40 am
Tipps und Tricks bei der ICG Sentinel-Technik
M. Reinisch
10.40 - 11.00 am
// COFFEE BREAK
SATELLITE SYMPOSIUM
  Chair: S. Kümmel
Current and Upcoming Treatment Strategies After CDK4/6i for Patients with ER+/HER2- Advanced Breast Cancer
11.00 - 11.05 am
Opening and Welcome
S. Kümmel
11.05 - 11.25 am
The Current and Future Treatment Landscape for ER+/HER2- Metastatic Breast Cancer
V. Kaklamani
11.25 - 11.40 am
Emerging Biomarkers in Breast Cancer: Implementing Liquid Biopsy ESR1 Mutation Testing
S. Kümmel
11.40 - 12.00 pm
Clinical Experience and Takeaways
V. Kaklamani, S. Kümmel
 
With the kind support of Stemline Menarini
INTERNATIONAL SESSION – RECONSTRUCTION
  Chair: S. Kümmel, J. Blohmer, V. Bjelic-Radisic
12.00 - 12.15 pm
Breast Surgery with Local Anaesthesia – How Far Can We Go?
F. Reyal
12.15 - 12.30 pm
Chest Wall Perforator Flaps for Multiple Ipsilateral Breast Cancer
G. Catanuto
12.30 - 12.45 pm
Neurotization of DIEP Flaps: The Missing »S« Autologous Breast Reconstruction
B. Behr
12.45 - 01.00 pm
Skin Reducing Immediate Breast Reconstruction – Could We Omit Sentinel Node in Mastectomy for Intraductal Breast Cancer
L. Darrigues
01.00 - 01.20 pm
Live Panel Discussion
L. Darrigues, J. Blohmer, S. Kümmel, F. Reyal, G. Catanuto, B. Behr
MASTER OF DISASTER – HOW TO SOLVE PROBLEMS
  Chair: S. Kümmel, F. Reyal, J. Blohmer, G. Catanuto
01.30 - 01.40 pm
Aesthetic Fat Closure After Mastectomy
H. Harrach
01.40 - 01.55 pm
Autologous Breast Reconstruction Without Microvascular Flaps
S. Polotto
01.55 - 02.10 pm
Margins – Where We Are and Where We Have to Go?
M. Thill
02.10 - 02.30 pm
KEM – Curie – Charité. An International Cooperation to Promote Science in Breast Surgery.
What Can We Learn From It?
E. Laas, L. Darrigues, T. Gaillard, S. Gipe, M. Reinisch, K. Weiler
02.30 - 02.35 pm
Live Discussion and Live Chat
02.35 - 03.00 pm
// LUNCH BREAK
SATELLITE SYMPOSIUM
  Chair: P. Harter, S. Kümmel
The Development Journey of Biomarker Driven Therapies in Gynaecological Oncology and Breast Cancer
03.00 - 03.20 pm
Endometrial Cancer
B. Ataseven
03.20 - 03.30 pm
Ovarian Cancer
B. Ataseven
03.30 - 03.50 pm
Hormone Receptor Positive Breast Cancer
M. Reinisch
03.50 - 04.00 pm
Discussion
 
With the kind support of AstraZeneca GmbH
PRE-PROGRAM: GYNECOLOGIC ONCOLOGY
SURGICAL WORKSHOP GYNECOLOGIC ONCOLOGY – PICTURES AND VIDEOS
  Chair: Chair: P. Harter, S. Mahner, C. Fotopoulou
04.00 - 04.20 pm
Management of Thoracic Disease
C. Fotopoulou
04.20 - 04.40 pm
Plastic Reconstruction in Advanced Vulvar Cancer
U. Wagner
04.40–05.00 pm
Techniques of Fertility Sparing Surgery in Cervical Cancer
N. R. Abu-Rustum
05.00 - 05.20 pm
Techniques of Bowel Resection and Indications for Stoma
J. Sehouli
05.20 - 05.40 pm
How to Plan and Conduct Resection of Thoracic Disease in Ovarian Cancer
D. Chi
05.40 - 06.00 pm
Splenectomy and Distal Pancreatic Resection
P. Alesi
06.00 - 06.20 pm
Bowel Leakage – Diagnostic Pathway and Management
O. Zivanovic
06.20 - 06.40 pm
Diaphragmatic Surgery
F. Heitz
FRIDAY, SEPTEMBER 6, 2024
MAIN PROGRAM: LIVE SURGERY + GYNECOLOGIC ONCOLOGY
08.00 - 12.00 pm
LIVE SURGERY
THEATER 1 ,2:
BREAST SURGERY – New OP Procedures, Tipps and Tricks for Solving Complications and Difficult Cases
Surgeons: J.-U. Blohmer, M. Warm, H. Rotthaus, R. Skoblinow, M. Reinisch, B. Behr, O. Chiari, H. Harrach, E. Bensmann, S. Kümmel
Chair: F. Reyal, K. Brunnert, M. Thill
THEATER 3, 4:
GYNECOLOGIC ONCOLOGY
Surgeons: P. Harter, D. Chi, G. Aletti,N. R. Abu-Rustum, S. Ehmann, M. Moubarak
Chair: A. du Bois, L. M. Chiva de Agustin, O. Zivanovic
12.00 - 12.40 pm
// LUNCH BREAK
SATELLITE SYMPOSIUM
  Chair: I. Ray-Coquard, S. Mahner
12.40 - 01.10 pm
New Treatment Options in Platinum Resistant Ovarian Cancer
T. van Gorp
01.10 - 01.40 pm
Endpoints in Difficult Clinical Situations.
What is Really Important?
F. Hilpert
 
With the kind support of ImmunoGen Switzerland GmbH
OVARIAN CANCER
  Chair: A. du Bois  |  Panel: C. Fotopoulou, D. Chi, A. González-Martin
01.40 - 02.00 pm
Help! – It’s Bleeding!
L. Chiva de Agustín
02.00 - 02.20 pm
Surgery for Recurrent Ovarian Cancer – Update 2024
S. Mahner
02.20 - 02.40 pm
IO in Ovarian Cancer
F. Marmé
02.40 - 03.00 pm
NACT, but Limited Response After Three Cycles – What Next?
G. Aletti
03.00 - 03.30 pm
// COFFEE BREAK
SATELLITE SYMPOSIUM
  Chair: P. Harter
Navigating Treatment Decisions in Endometrial and Ovarian Cancer – Current Insights and Future Ambition
03.30 - 04.00 pm
Rethinking Maintenance Therapy in Ovarian Cancer Treatment
A. González-Martin, F. Marmé
04.00 - 04.30 pm
Endometrial Cancer Therapy Management from Clinical Study to Clinical Practices
D. Lorusso
 
With the kind support of GlaxoSmithKline GmbH & Co. KG
CERVICAL CANCER
  Chair: N. Colombo, N. R. Abu-Rustum
04.30 - 04.50 pm
When SLN and When LNE in Cervical Cancer
C. Grimm
04.50 - 05.10 pm
TInduction Chemotherapy or IO in Locally Advanced Cervical Cancer
D. Lorusso
05.10 - 05.30 pm
Best Options After Platinum Based Chemotherapy
I. Ray-Coquard
05.30 - 05.45 pm
// COFFEE BREAK
THE FINAL OPEN QUESTIONS
  Chair: P. Harter, O. Zivanovic
05.45 - 06.05 pm
Role of Surgery in Cervical Cancer – Simple or Radical Hysterectomy?
Surgery at Relapse?
C. Fotopoulou
06.05 - 06.25 pm
Surgical Management of Primary Endometrial Cancer in the Era of Molecular Classification
C. Marth
06.25 - 06.45 pm
ENGOT Trials: Novel Drugs in Gynecologic Oncology – My Personal Favorites
N. Colombo
SATURDAY, SEPTEMBER 7, 2024
MAIN PROGRAM: BREAST CANCER
EARLY BIRD SYMPOSIUM
  Chair: S. Kümmel
Breaking New Ground - Emerging Roles in Early HR+/HER2- Breast Cancer
08.15 - 08.20 am
Introduction
S. Kümmel
08.20 - 08.35 am
hat´s Next for Early HR+/HER2- Breast Cancer Therapy?
S. Kümmel
08.35 - 09.00 am
Case-based Discussion on Treatment Decisions in HR+/HER2- Breast Cancer
N. Harbeck, M. Thill
 
With the kind support of Novartis Pharma GmbH
UPDATE ON SYSTEMIC TREATMENT IN BREAST CANCER:
WHAT IS PROVEN, WHAT IS COMING NEXT?
  Chair: S. Kümmel
09.00 - 09.20 am
Triple-Negative Breast Cancer – From Early to Metastatic Disease
P. Schmid
09.25 - 09.55 am
HER2/neu-Positive Disease – From Early to Metastatic Disease
R. Bartsch
10.00 - 10.20 am
HR-Positive Early Breast Cancer – Who Needs Chemotherapy?
O. Gluz
10.25 - 10.45 am
HR-Positive Metastatic Breast Cancer – Which Drugs
N. Harbeck
10.45 - 11.00 am
// COFFEE BREAK
LOCAL THERAPY I – AXILLA SURGERY
  Chair: M. Reinisch, A. S. Caudle, W. Weber
11.00 - 11.15 am
Is Tc99m Still The Gold Standard for Sentinel Lymphadenectomy?
S. Kümmel
11.15 - 11.35 am
After Neoadjuvant Systemic Therapy – Sentinel Only or TAD?
And: Are Still at Least Three Lymphnodes a Gold Standard to Determine Nodal pCR?
A. Caudle
11.35 - 11.50 am
De-Escalation of Surgical Therapies in Elderly: What Can We Safely Offer?
S. Gipe
11.50 - 12.05 pm
Live Discussion and Live Chat
12.05 - 12.45 pm
// LUNCH BREAK
LOCAL THERAPY II
  Chair: F. Reyal, K. Ferentinos, A. Caudle
12.45 - 01.10 pm
After Neoadjuvant Systemic Therapy – Radiation or Axillary Surgery for Residual Nodal Disease
W. Weber
01.10 - 01.25 pm
ARadiotherapy After Neoadjuvant Systemic Therapy – Where Can We De-Escalate?
Who needs it all?
K. Ferentinos
01.25 - 01.40 pm
OMD – Surgery? Radiotherapy? Both? – Or Only Systemic Therapy?
M. Reinisch
SCIENTIFIC SYMPOSIUM
  Chair: S. Kümmel
The Great Debate - CDK4/6i Emerging Role in Early HR+/HER2- Breast Cancer
01.40 - 02.10 pm
ADCs in First Line: Becoming Reality Soon?
G. Curgliano
02.10 - 02.40 pm
ADCs in First Line: What is Coming Next?
N. Harbeck
 
With the kind support of Daiichi Sankyo Deutschland GmbH
02.40 - 03.10 pm
// COFFEE BREAK
WHAT WE CAN LEARN FROM OTHER SUBJECTS?
  Chair: M. Thill, B. Behr
03.10 - 03.30 pm
»Scar Treatment – Next Level«
I. Stoffels
03.30 - 03.45 pm
What Do Dermatologists Differently With Seromas?
J. Klode
03.45 - 04.00 pm
Prophylaxis of Lymphedema – Is there a Surgical Intervention?
M. Wagner
| Status: July 2024; may be subject to change |